AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Full Length Article | Open Access

Mitochondria-derived small RNAs as diagnostic biomarkers in lung cancer patients through a novel ratio-based expression analysis methodology

Zongtao Yua,b,1Shaoqiu Chenc,d,1Zhenming Tange,1Ying Tange,1Zhougui Linge( )Hongwei WangfTing Gongc,dZitong Gaoc,dGehan Devendrac,gGang Huangh( )Wei Cheni( )Youping Dengc( )
Department of Laboratory Medicine, Affiliated Taihe Hospital of Xi'an Jiaotong University Health Science Center, Shiyan, Hubei 710061, China
Department of Internal Medicine, Rush University Cancer Center, Rush University Medical Center, Kidston House, Chicago, IL 60612, USA
Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
Molecular Biosciences and Bioengineering Program, College of Tropical Agriculture and Human Resources, The University of Hawaii at Manoa, Honolulu, HI 96822, USA
Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi 545005, China
Division of Research and Development, Decoding Therapeutics Corp, Mt Prospect, IL 60056, USA
Division Chief Pulmonary & Critical Care Medicine, The Queen’s Medical Center, John A Burns School of Medicine, Honolulu, HI 96813, USA
Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

Abstract

Small non-coding RNAs are potential diagnostic biomarkers for lung cancer. Mitochondria-derived small RNA (mtRNA) is a novel regulatory small non-coding RNA that only recently has been identified and cataloged. Currently, there are no reports of studies of mtRNA in human lung cancer. Currently, normalization methods are unstable, and they often fail to identify differentially expressed small non-coding RNAs (sncRNAs). In order to identify reliable biomarkers for lung cancer screening, we used a ratio-based method using mtRNAs newly discovered in human peripheral blood mononuclear cells. In the discovery cohort (AUC = 0.981) and independent validation cohort (AUC = 0.916) the prediction model of eight mtRNA ratios distinguished lung cancer patients from controls. The prediction model will provide reliable biomarkers that will allow blood-based screening to become more feasible and will help make lung cancer diagnosis more accurate in clinical practice.

References

1

Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA A Cancer J Clin. 2021;71(1):7–33.

2

The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

3

Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol. 2019;14(3):343–357.

4

Chen Y, Zitello E, Guo R, et al. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin Transl Med. 2021;11(4):e367.

5

Hu L, Ai J, Long H, et al. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget. 2016;7(8):8441–8454.

6

Yu Z, Chen H, Zhu Y, et al. Global lipidomics reveals two plasma lipids as novel biomarkers for the detection of squamous cell lung cancer: a pilot study. Oncol Lett. 2018;16(1):761–768.

7

Chen H, Liu H, Zou H, et al. Evaluation of plasma miR-21 and miR-152 as diagnostic biomarkers for common types of human cancers. J Cancer. 2016;7(5):490–499.

8

Roberts ER, Thomas KJ. The role of mitochondria in the development and progression of lung cancer. Comput Struct Biotechnol J. 2013;6:e201303019.

9

Larriba E, Rial E, Del Mazo J. The landscape of mitochondrial small non-coding RNAs in the PGCs of male mice, spermatogonia, gametes and in zygotes. BMC Genom. 2018;19(1):634.

10

Uddin A, Chakraborty S. Role of miRNAs in lung cancer. J Cell Physiol. 2018:1–10.

11

Mourksi NE, Morin C, Fenouil T, et al. snoRNAs offer novel insight and promising perspectives for lung cancer understanding and management. Cells. 2020;9(3):541.

12

Fathizadeh H, Asemi Z. Epigenetic roles of PIWI proteins and piRNAs in lung cancer. Cell Biosci. 2019;9:102.

13

Deng Y, Zhu Y, Wang H, et al. Ratio-based method to identify true biomarkers by normalizing circulating ncRNA sequencing and quantitative PCR data. Anal Chem. 2019;91(10):6746–6753.

14

Shen J, Chang SI, Lee ES, et al. Determination of cluster number in clustering microarray data. Appl Math Comput. 2005;169(2):1172–1185.

15

Dou Y, Zhu Y, Ai J, et al. Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening. BMC Genom. 2018;19(1):545.

16

Zuo Y, Chen S, Yan L, et al. Development of a tRNA-derived small RNA diagnostic and prognostic signature in liver cancer. Genes Dis. 2021;9(2):393–400.

17

Shi J, Ko EA, Sanders KM, et al. SPORTS1.0: a tool for annotating and profiling non-coding RNAs optimized for rRNA-and tRNA-derived small RNAs. Dev Reprod Biol. 2018;16(2):144–151.

18

Ewels PA, Peltzer A, Fillinger S, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276–278.

19

Jühling F, Mörl M, Hartmann RK, et al. tRNAdb 2009: compilation of tRNA sequences and tRNA genes. Nucleic Acids Res. 2009;37(Database issue):D159–D162.

20

Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166–169.

21

Wei R, Wang J, Su M, et al. Missing value imputation approach for mass spectrometry-based metabolomics data. Sci Rep. 2018;8(1):663.

22

Pinsky PF, Gierada DS, Black W, et al. Performance of lung-RADS in the National lung screening trial: a retrospective assessment. Ann Intern Med. 2015;162(7):485–491.

23

Reznik E, Wang Q, La K, et al. Mitochondrial respiratory gene expression is suppressed in many cancers. Elife. 2017;6:e21592.

24

Reznik E, Miller ML, Şenbabaoğlu Y, et al. Mitochondrial DNA copy number variation across human cancers. Elife. 2016;5:e10769.

25

Nam HS, Izumchenko E, Dasgupta S, et al. Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? Biomarkers Med. 2017;11(6):475–489.

26

Bratic A, Larsson NG. The role of mitochondria in aging. J Clin Invest. 2013;123(3):951–957.

27

Servais S, Couturier K, Koubi H, et al. Effect of voluntary exercise on H2O2 release by subsarcolemmal and intermyofibrillar mitochondria. Free Radic Biol Med. 2003;35(1):24–32.

Genes & Diseases
Pages 1055-1061
Cite this article:
Yu Z, Chen S, Tang Z, et al. Mitochondria-derived small RNAs as diagnostic biomarkers in lung cancer patients through a novel ratio-based expression analysis methodology. Genes & Diseases, 2023, 10(3): 1055-1061. https://doi.org/10.1016/j.gendis.2022.07.013

303

Views

2

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Altmetrics

Received: 07 April 2022
Revised: 01 July 2022
Accepted: 16 July 2022
Published: 07 August 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return